Search research articles
Contact Us
Filters
Showing results (321-330 of 367) with videos related to
Page
of 37
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2025
Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study
Hani M Babiker, Vincent Picozzi, Sreenivasa R Chandana, et al.
BMC Geriatrics
|
November 17, 2021
A complex intervention to promote prevention of delirium in older adults by targeting caregiver's participation during and after hospital discharge - study protocol of the TRAnsport and DElirium in older people (TRADE) project
Christoph Leinert, Simone Brefka, Ulrike Braisch, et al.
United European Gastroenterology Journal
|
March 28, 2020
Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response
Pierre-Olivier Frappart, Karolin Walter, Johann Gout, et al.
Stem Cell Reports
|
December 10, 2013
TBX3 Directs Cell-Fate Decision toward Mesendoderm
Clair E Weidgang, Ronan Russell, Purushothama R Tata, et al.
Journal of Internal Medicine
|
July 16, 2023
Implementation of precision medicine in healthcare-A European perspective
Albrecht Stenzinger, Ejner K Moltzen, Eva Winkler, et al.
Stem Cell Reports
|
January 13, 2017
TBX3 Directs Cell-Fate Decision toward Mesendoderm
Clair E Weidgang, Ronan Russell, Purushothama R Tata, et al.
The Journal of Pathology
|
February 5, 2025
Unveiling the intriguing relationship: oncogenic KRAS, morphological shifts, and mutational complexity in pancreatic mucinous cystic neoplasms
Lucas-Alexander Schulte, Annika Beck, Ralf Marienfeld, et al.
Frontiers in Immunology
|
September 28, 2020
Thirty-Eight-Negative Kinase 1 Is a Mediator of Acute Kidney Injury in Experimental and Clinical Traumatic Hemorrhagic Shock
Rebecca Halbgebauer, Ebru Karasu, Christian K Braun, et al.
Cancer Research
|
February 3, 2021
RINT1 Regulates SUMOylation and the DNA Damage Response to Preserve Cellular Homeostasis in Pancreatic Cancer
Frank Arnold, Johann Gout, Heike Wiese, et al.
The Lancet. Oncology
|
May 24, 2014
Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial
David Malka, Pascale Cervera, Stéphanie Foulon, et al.
Page
of 37
Search research articles
Search
Showing results (321-330 of 367) with videos related to
Sort By:
Page
of 37
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2025
Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study
Hani M Babiker, Vincent Picozzi, Sreenivasa R Chandana, et al.
BMC Geriatrics
|
November 17, 2021
A complex intervention to promote prevention of delirium in older adults by targeting caregiver's participation during and after hospital discharge - study protocol of the TRAnsport and DElirium in older people (TRADE) project
Christoph Leinert, Simone Brefka, Ulrike Braisch, et al.
United European Gastroenterology Journal
|
March 28, 2020
Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response
Pierre-Olivier Frappart, Karolin Walter, Johann Gout, et al.
Stem Cell Reports
|
December 10, 2013
TBX3 Directs Cell-Fate Decision toward Mesendoderm
Clair E Weidgang, Ronan Russell, Purushothama R Tata, et al.
Journal of Internal Medicine
|
July 16, 2023
Implementation of precision medicine in healthcare-A European perspective
Albrecht Stenzinger, Ejner K Moltzen, Eva Winkler, et al.
Stem Cell Reports
|
January 13, 2017
TBX3 Directs Cell-Fate Decision toward Mesendoderm
Clair E Weidgang, Ronan Russell, Purushothama R Tata, et al.
The Journal of Pathology
|
February 5, 2025
Unveiling the intriguing relationship: oncogenic KRAS, morphological shifts, and mutational complexity in pancreatic mucinous cystic neoplasms
Lucas-Alexander Schulte, Annika Beck, Ralf Marienfeld, et al.
Frontiers in Immunology
|
September 28, 2020
Thirty-Eight-Negative Kinase 1 Is a Mediator of Acute Kidney Injury in Experimental and Clinical Traumatic Hemorrhagic Shock
Rebecca Halbgebauer, Ebru Karasu, Christian K Braun, et al.
Cancer Research
|
February 3, 2021
RINT1 Regulates SUMOylation and the DNA Damage Response to Preserve Cellular Homeostasis in Pancreatic Cancer
Frank Arnold, Johann Gout, Heike Wiese, et al.
The Lancet. Oncology
|
May 24, 2014
Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial
David Malka, Pascale Cervera, Stéphanie Foulon, et al.
Page
of 37